Albert Bourla, Pfizer CEO (Steven Ferdman/Getty Images)

As Pfiz­er's stock surged Mon­day, Al­bert Bourla net­ted $5.6M in stock sales

On Mon­day morn­ing, Pfiz­er an­nounced they had de­vel­oped the first ef­fec­tive Covid-19 vac­cine, the world cel­e­brat­ed, their stock jumped 13% and their CEO be­came $5.6 mil­lion rich­er.

In an SEC fil­ing Tues­day, Pfiz­er CEO Al­bert Bourla dis­closed he sold off 132,508 shares at the peak of the Mon­day surge for $41.92 a piece. Bourla’s sale is kosher be­cause it was planned and pre-ap­proved in Au­gust for when the stock hit a cer­tain price, but it adds the Big Phar­ma chief to the list of ex­ec­u­tives who have drawn scruti­ny for sell­ing shares as their com­pa­ny’s Covid-19 ef­forts pro­gressed and stocks rose.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.